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Summary. Salmon calcitonin (sCT) at doses of 100 and 50 
UI given subcutaneously to growing rats produced in vivo 
evidence of osteoclastic activity inhibition. Histological as- 
sessment was carried out by measuring the perichondrial 
ring of Lacroix height, and a dose-correlated effect was 
found. These aspects were coupled with an increase in the 
osteoclast number and suggested that in studies with bone 
resorption inhibitors, morphological evaluation based on os- 
teoclasts count is not reliable. The changes of the metaphy- 
sis suggested also that sCT affects the activity of hyper- 
trophic chondrocytes of the growth plate. Plasma calcium 
levels did not differ significantly between treated rats and 
controls; an increased phosphatemia was observed in sCT- 
treated animals. 
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The capacity of calcitonin to inhibit bone resorption has 
been demonstrated with organ culture techniques [1-4] and 
in experiments with isolated osteoclasts cultured on calcified 
substrates [5-7]; on the other hand, there are few histological 
evidences of such an effect in experimental nimals [8], al- 
though morphological changes of osteoclasts have been ob- 
served with electron microscopy [9, 10]. The reported sig- 
nificant decrease in number of osteoclasts following admin- 
istration of calcitonin [1, 11, 12] is not necessarily related to 
the level of resorption activity; on the contrary, other potent 
inhibitors of bone resorption, such as diphosphonates, in-
crease the number of osteoclasts, but they are not active 
[13]. The tibial growth plate cartilage and the related peri- 
chondrial ring of Lacroix [14, 15] are characterized by fast 
modeling, therefore, they are a suitable model for the study 
of early changes of osteoclasts morphology and activity. No 
effects of calcitonin were observed employing histological 
techniques in rats, which received current herapeutic doses 
[8]. In this study, the experiment was carried out with high 
doses of salmon calcitonin to investigate he effectiveness of
the hormone in inhibiting bone resorption in the fast model- 
ing metaphysis of growing rats. The conical shape of the 
metaphysis the result of high rate modeling of the peri- 
chondrial ring and metaphyseal primary trabeculae, and thus 
an inhibitory effect on bone resorption should soon become 
apparent as a modification of the morphology of the metaph- 
ysis [16]. 
Offprint requests to: U. E. Pazzaglia 
Table 1. Mean plasmatic levels of calcium and phosphates in rats 
treated with sCT (100 and50 U daily) for 21 days and controls 
Plasma calcium Plasma phosphate 
Group (mg/100 ml -+ SD) (mg/100 ml +- SD) 
A (CT 100 U) n = 10 10.61 -+ 0.33 9.65 -+ 0.64 a 
B (CT 50 U) n = 10 10.09 -+ 0.76 10.18 +- 0.858 
C (Controls) n = 10 10.34 +- 0.45 8.70 -+ 0.49 
Mean of group A and B were compared with C using Student's t test 
a p < 0.002; bp < 0.001 
Materials and Methods 
Thirty Sprague-Dawley rats (Stefano Morini, S. Polo d'Enza, Reg- 
gio Emilia, Italy) weighing about 150 g were used, randomly distrib- 
uted in three groups of 10 animals each. The rats in group A received 
100 U of sCT daily (Sandoz S.p.A., Milano, Italy) subcutaneously 
and those in group B received 50 U of sCT daily: the 10 control rats 
of group C were treated daily with the same volume of the vehicle 
alone for 21 days. 
Rats were housed three to a cage with free access to food and 
water. They were killed with an ether overdose after 21 days. The 
interval between the sacrifice and the last administration f sCT was 
8 hours. About 30 cc of blood was drawn from the heart with a hep- 
arinized syringe; the samples were centrifuged and the plasma was 
stored in a freezer at -30~ until analyzed. 
Plasma levels ofcalcium and phosphates were assessed with the 
method of o-cresolphthalein-complexon in alkaline solution [17], 
plasma phosphate with the direct phosphomolybdate reaction with- 
out deproteinization [18]. 
The right and left tibia of each animal were carefully dissected 
from soft tissues without damaging periosteum and p richondrium; 
the left ibia was fixed in neutral formalin (10%). Eight specimens 
were decalcified with EDTA, cut in the middle, coronal plane of the 
metaphysis and embedded in paraffin. Sections were stained with 
hematoxylin-eosin. The remaining two specimens were embedded 
undecalcified in Technovit resin (Kulzer and Co., Gmgh, 
Wehrheim, FRG), and sections of the middle coronal plane of the 
metaphysis were prepared with a cutting-grinding machine (Exact 
Apparatebau, Norderstadt, FRG). Sections of 25-1~m thickness were 
stained by the Von-Kossa method (counterstained with neutral red). 
The number of osteoclasts was determined in a median coronal sec- 
tion of the proximal tibia of each rat, including thewhole epiphysis, 
metaphysis, and proximal diaphysis. Only multinuclear cells in con- 
tact with a resorption lacunae on the bone surface were identified as 
osteoclasts. The height of the perichondrial ring was measured un- 
der the microscope with a graduated reticulum. 
Right tibias were freed of periosteum and all soft tissues, stored 
for 7 days in an ethanol-methanol solution (50:50) at 27~ to extract 
lipids and water, and then dried in an oven at 100~ for 48 hours. 
They were then weighed and the lengths were measured with a 
caliber. 
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Table 2. Mean dry weight and length of tibia in rats treated with sCT 
(100 and 50 U daily) and controls for 21 days 
Tibias weight Tibias length 
Group (g -+ SD) (mm -+ SD) 
A (CT 100 U) n = 10 0.361 -+ 0.41 34.6 -+ 0.3 
B (CT 50 U) n = 10 0.345 -+ 0.035 34.8 -+ 0.7 
C (Controls) n = 10 0.340 +- 0.033 35.2 -+ 1.2 
Mean of group A and B were compared with C using Student's t test 
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Observations 
Treatment was well tolerated by the rats: no animals died during the 
experiment, and the behavior and weight gain of the animals in 
groups A and B were normal. Eight hours after the last administra- 
tion of sCT there were no significant differences in plasma calcium 
levels between treated animals and controls; mean plasma phos- 
phate was significantly higher in both treated groups compared with 
controls (Table 1). 
The difference in tibial mean dry weight and length between rats 
Fig. 1. Left: proximal tibial metaphysis of 
control rats. Right: proximal tibial metaphysis 
of rats treated with sCT 100 U daily for 21 
days. Thickening of the outer part of the 
growth plate is evident as well as the 
cylindrical shape of one side of the 
metaphysis, due to failure of remodeling. 
Original magnification x 3.3, 
hematoxylin-eosin. 
Fig. 2. Failure of calcification of intercolumnar septa of the thickened growth plate cartilage. The metaphyseal trabeculae are thicker and 
denser than normal, due to inhibition of remodeling, x40, Von KossaJneutral red. 
Fig. 3. Normal aspect of the perichondrial bone bark. It does not extend below the line of primary metaphyseal trabeculae and is resorbed 
at its distal end by osteoclasts (arrows). x 100, hematoxylin-eosin. 
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Fig. 4. The effect of sCT on the height of 
perichondrial bone bark (left: control, right: CT 100 
U daily for 21 days), x30, hematoxylin-eosin. 
treated with sCT and controls was not significant (Table 2). The 
morphology of the growth plate cartilage and metaphysis n groups 
A and B was different from that in controls in quantity but not in 
quality. The growth plate cartilage showed an increased thickness of 
its outer part (Fig. 1). This thickening was not symmetrical and in 
most bones it involved only the medial side of the tibia. Thickening 
was due to persistence of hypertrophic hondrocytes because of 
failure of vascular invasion from the metaphysis. The proximal tibial 
metaphysis on the affected side showed an inversion of the concav- 
ity of its profile (failure of conization). Primary metaphyseal trabec- 
ulae were denser and thicker in this area (Fig. 2), as is usually 
observed when inhibition of resorption is coupled with a normal rate 
of osteoblastic apposition [25]. In the thickened growth plate failure 
of calcification of the inlercolumnar septa was present (Fig. 2); cal- 
cification and vascular invasion were normal in the other sectors of 
the plate. No pathological osteoid border was present on trabeculae 
or cortical bone. 
The perichondrial ring [14, 15, 19-21], which normally does not 
extend below the line of the first primary metaphyseal trabeculae 
(Fig. 3) and has the appearance of a very thin lamina without osteo- 
cytes, was higher in the sCT-treated animals than in controls be- 
cause it lined the thickened growth plate and the unremodeled me-
taphysis. Also, the thickness of the ring was increased and osteo- 
cytes were present in the structure. 
Because the proximal and distal ends of the perichondrial ring 
were easily identified on histological sections, its height could be 
measured (Fig. 4) and a significant difference was found when 
groups A and B were compared with controls (Table 3). 
In the lower part of the metaphysis, a row of osteoclasts lined the 
bone below the periosteum. The number of osteoclasts and the ratio 
nuclei/osteoclast were significantly higher than in controls (Table 4). 
The nuclei had a dense chromatin and appeared to have an abnor- 
mally high number of picnotic nuclei (Fig. 5). 
Discussion 
No effects of calcitonin on the chemistry  and histology of the 
rats'  bones were observed in a previous report  [8], but the 
dose used was small (200 mU/day).  In the present  experi- 
Table 3. Mean height of the perichondrial ring in rats treated with 
sCT (100 and 50 U daily) for 21 days and controls 
Group Height (ram -+ SD) 
A n = 15 2.70 + 1.05 a 
B n = 12 2.21 ----- 0 .84  b 
C n = 14 1.35 -+ 0.32 
Mean of groups A and B were compared with C using Student's t 
test 
ap  < 0.001; bp = 0.001 
Table 4. Mean number of osteoclasts/mm 2 and mean ratio nuclei/ 
osteoclast in rats treated with sCT (100 and 50 U daily) for 21 days 
and controls 
Number of 
Group osteoclasts/mm 2 Nuclei/Osteoclast 
A n = 10 1.14 +- 0.56 a 5.24 -+ 0.37 a 
B n = 10 0.98 - 0.31 a 4.98 -+ 0.39 b 
C n = 10 0.41 - 0.17 4.25 -+ 0.67 
Mean of groups A and B were compared with C using Student's t 
test 
a p <0.001; bp = 0.008 
ment,  50 and 100 IU/day were used, as current ly given in 
clinical therapy. Consider ing the body weight of rats, these 
doses are high, a l though compar ison of the dose/body weight 
ratio in different species is quest ionable.  I f calcitonin is rap- 
idly cleared from the circulation in the rat, high doses are 
necessary to induce the inhibitory response on bone turn- 
over. However ,  the aim of this study was not to invest igate 
the effectual doses of calcitonin in the rat, but to conf irm 
histologically in vivo the effects observed in in vitro studies. 
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Fig. 5. Proximal tibial metaphysis of rats treated with sCT 100U 
daily for 21 days. A row of osteoclasts is evident on the outer aspect 
of the metaphysis; they appear abnormally large and with an abnor- 
really high number of picnotic nuclei, x 100 and x 400, hematoxilin- 
eosin. 
Most changes of the growth plate and metaphyseal mor- 
phology observed by us can be explained in terms of inhibi- 
tion of bone resorption and vascular invasion of cartilage 
[16]; the inhibition due to sCT involved only the outer part of 
the epiphyseal plate and this area was characterized by three 
basic phenomena: (1) inhibition of osteoclastic resorption; 
(2) reduced mineralization of intercolumnar septa; and (3) 
failure of vascular invasion. 
It is difficult to explain the different response of the same 
anatomical structure to sCT, as well as the association of 
inhibition of mineralization and failure of bone resorption 
and vascular invasion of cartilage. The conical shape of the 
proximal tibial metaphysis results from a high remodeling 
rate, and under normal conditions, many more osteoclasts 
are observed on the outer border of the metaphysis than 
anywhere else in the bone. As osteoclasts are the major 
target cells of calcitonin, the inhibitory effects of the hor- 
mone obviously becomes evident earlier at sites where os- 
teoclastic activity is higher. This could account for a differ- 
ent response to he hormone of different parts of the growth 
plate cartilage and metaphysis. 
Attachment of osteoclasts o bone surface is a necessary 
condition for the activity of these cells both in vitro and in 
vivo; there are evidences that calcitonin is capable of inhib- 
iting both mobility of osteoclasts in vitro and their attach- 
ment to the bone surface [6, 22]; therefore, a quantitative 
evaluation of in vivo bone resorption inhibition based on 
morphology is questionable. The osteoclast count has been 
used [11, 23], but it is not a reliable index, as the number of 
cells does not necessarily correlate with their degree of ac- 
tivity. In this study, the number ofosteoclasts was observed 
to increase in the presence of an arrest of bone modeling. 
Explanation of these observations can only be specula- 
tive: either the formation of osteoclasts i enhanced, or the 
life-span of inactive osteoclasts i lengthened and the cells 
accumulate at the resorption sites, or the large polykarios 
are easier identified in the histological s ides, and the ob- 
served differences represent a technical artifact. On the con- 
trary measurement of the perichondrial ring of Lacroix 
proved to be a simple and reliable method for assessing os- 
teoclastic resorption inhibition and allowed comparison be- 
tween groups. The inhibitory effect was proportional to the 
dose of the hormone (Table 3). On the other hand, there was 
no inhibitory effect on osteoblastic activity, as demonstrated 
by the thickness of perichondrial ring and primary metaph- 
yseal trabeculae. 
The sequence of phenomena that characterizes growth 
plate cartilage maturation suggests a correlation between 
cartilage mineralization and cartilage invasion by vessels. 
The nature of this relationship remains obscure. However, 
recent observations have cast doubts on the notion that 
chondrocytes in the lowermost hypertrophic zone are degen- 
erating [24] and have suggested that the hypertrophic chon- 
drocyte is a highly differentiated cell, which synthetizes and 
secretes into extracellular matrix a set of macromolecules, 
such as type • collagen, chondrocalcin, and S-100 protein, 
which may be directly involved in the processes of matrix 
mineralization and capillary invasion [25-27]. The effects on 
mineralization of intercolumnar septa and vascular invasion 
could indicate that calcitonin has an influence on the activity 
of hypertrophic chondrocytes. 
In another study [28] in which sCT 10 IU was given for 3 
and 7 days to rats weighing 20-30 g (approximately the same 
dose as given to group A animals in our experiment), a wid- 
ening of the metatarsal growth plate cartilage was observed. 
Although these authors explain their findings in terms of 
stimulation of chondrocyte maturation, their observations 
confirm our results. 
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Calcitonin has been reported to have a hypocalcemic ef- 
fect whose magnitude and duration depends on the dose [29]; 
4 hours after administration f high doses of sCT (0.4 and 2 
IU/100 g), hypocalcemia nd secondary hyperparathy- 
roidism have been observed [14]; the consequent increase of 
PTH and 1,25-dihydroxycolecalciferol secretion are known 
to enhance the formation of osteoclasts, while this effect is 
prevented by parathyroidectomy [30]. The increased number 
of osteoclasts and nuclei/osteoclast in the present experi- 
ment probably reflects transient changes of plasmatic al- 
cium levels. However, as blood sampling was performed 8
hours from the last sCT administration, the animals have 
possibly compensated for the low calcium levels in plasma, 
whereas phosphate remained higher. 
In conclusion, treatment with very high doses of sCT was 
well tolerated by rats and produced histological evidences of 
osteoclastic activity inhibition; these aspects were coupled 
with an increase of the osteoclast number and suggested that 
morphological evaluation based on osteoclast count is not 
reliable. 
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